NovoCure Ltd. (NVCR)
13.22
-0.30
(-2.22%)
USD |
NASDAQ |
Mar 03, 15:53
NovoCure EPS Diluted (Quarterly) : -0.2183 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| LivaNova Plc | 0.5566 |
| AtriCure, Inc. | 0.0366 |
| Abbott Laboratories | 1.030 |
| Accuray, Inc. | -0.1138 |
| Plus Therapeutics, Inc. | -0.0412 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -24.50M |
| Revenue (Quarterly) | 174.35M |
| Total Expenses (Quarterly) | 198.85M |
| Enterprise Value | 1.305B |
| Gross Profit Margin (Quarterly) | 75.82% |
| Profit Margin (Quarterly) | -14.05% |
| Earnings Yield | -9.25% |
| Normalized Earnings Yield | -9.246 |